| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |